Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure–Activity Relationships and Antileukemia Effects of the Tricyclic Benzoic Acid FTO Inhibitors
Zeyu Liu, Zongliang Duan, Deyan Zhang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 15, pp. 10638-10654
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
A covalent compound selectively inhibits RNA demethylase ALKBH5 rather than FTO
Gan-qiang Lai, Yali Li, Heping Zhu, et al.
RSC Chemical Biology (2024) Vol. 5, Iss. 4, pp. 335-343
Open Access | Times Cited: 14
Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties
Pan Xiao, Zongliang Duan, Zeyu Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9731-9752
Closed Access | Times Cited: 28
Chemical Inhibitors Targeting the Oncogenic m6A Modifying Proteins
Yue Huang, Wenyang Xia, Ze Dong, et al.
Accounts of Chemical Research (2023) Vol. 56, Iss. 21, pp. 3010-3022
Closed Access | Times Cited: 28
Small molecule inhibitors targeting m6A regulators
Guotai Feng, Yongya Wu, Yuan Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 10
Emerging roles of m6A RNA modification in cancer therapeutic resistance
Weiwei Liu, Zhongyuan Zhang, Fei Wang, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy
Lu Liu, Yuanlai Qiu, Yuying Suo, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5382-5392
Open Access | Times Cited: 6
Discovery of Novel RNA Demethylase FTO Inhibitors Featuring an Acylhydrazone Scaffold with Potent Antileukemia Activity
Xuewu Liang, Yue Huang, Hairu Ren, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Development of 3-Arylaminothiophenic-2-carboxylic Acid Derivatives as New FTO Inhibitors Showing Potent Antileukemia Activities
Deyan Zhang, Lu Liu, Ming Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117444-117444
Closed Access
Epigenetic Targets and Their Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis
Xiaohui Miao, Pan Liu, Yangyang Liu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117463-117463
Closed Access
A patenting perspective of fat mass and obesity associated protein (FTO) inhibitors: 2017-present
Ze Dong, Yue Huang, Wenyang Xia, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Demethylases in tumors and the tumor microenvironment: Key modifiers of N6-methyladenosine methylation
Junchen Guo, Liang Zhao, Meiqi Duan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116479-116479
Open Access | Times Cited: 4
Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy
Angel Guan, Justin Wong
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 4
The Functional Role and Regulatory Mechanism of FTO m6A RNA Demethylase in Human Uterine Leiomyosarcoma
Qiwei Yang, Ayman Al‐Hendy
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7957-7957
Open Access | Times Cited: 11
Structure‐Activity Relationships of 2‐(Arylthio)benzoic Acid FTO Inhibitors
Chao Guo Yan, Qian Zhang, Pan Xiao, et al.
Israel Journal of Chemistry (2024) Vol. 64, Iss. 3-4
Closed Access | Times Cited: 3
A new perspective on hematological malignancies: m6A modification in immune microenvironment
Shiyu Yang, Liping Xu, Haihui Zhuang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications
Dong Wang, Yan Zhang, Qingbo Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115477-115477
Open Access | Times Cited: 8
Abnormal changes in metabolites caused by m6A methylation modification: The leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application
Liang Zhao, Junchen Guo, Shasha Xu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Small molecules that regulate the N6-methyladenosine RNA modification as potential anti-cancer agents
Noah J. Harrahill, M. Kyle Hadden
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116526-116526
Closed Access | Times Cited: 2
RNA m6A modification in prostate cancer: A new weapon for its diagnosis and therapy
Zeyu Han, Xianyanling Yi, Jin Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188961-188961
Closed Access | Times Cited: 7
Decoding the epitranscriptome: a new frontier for cancer therapy and drug resistance
Lu Tang, Hua Tian, Min Qi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
A review on the role of RNA methylation in aging-related diseases
Wei Hong, Yuhao Xu, Li Lin, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127769-127769
Closed Access | Times Cited: 4
Medicinal chemistry aspects of fat mass and obesity associated protein: structure, function and inhibitors
Changyu Ren, Zhi Cao, Yang Liu, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 16, pp. 1705-1726
Closed Access | Times Cited: 1
An RNA Methylation-Sensitive AIEgen-Aptamer Reporting System for Quantitatively Evaluating m6A Methylase and Demethylase Activities
Xiner Ying, Chenyang Huang, Tengwei Li, et al.
ACS Chemical Biology (2023) Vol. 19, Iss. 1, pp. 162-172
Closed Access | Times Cited: 3
Insights into the role of RNA m6A modification in the metabolic process and related diseases
Haiming Hu, Zhibin Li, Xia Xie, et al.
Genes & Diseases (2023) Vol. 11, Iss. 4, pp. 101011-101011
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top